Intrinsic health importance or strong evidence for prediction or benefit on major health outcomes. |
Major health outcome affecting QOL (e.g., MI, LEA). |
Biomarker or intervention with clear causal linkage to health outcome. |
Process, intervention, or factor with potential linkage. |
Modifiable with scalable interventions targeting the metric. |
Clearly efficacious and scalable via evidence-based means. |
Moderately efficacious and scalable. |
Lacking clear scalability – or – clear health effect if scalable. |
Strong global data availability with acceptable measurement properties. |
Currently available for 75% of countries. |
Currently available for 25 - 75% of countries. |
Available for fewer than 25% of countries. |
International gap and disparity
|
Large proportion of population affected and large international variation |
Large proportion of population affected – OR - large international variation |
Modest international gap or limited variation |